$327.87 Original price was: $327.87.$240.00Current price is: $240.00.
By John Eble, Pedram Argani, Liang Cheng, and David J. Grignon, renowned authors in the field of pathology, comes a monumental publication that chronicles the remarkable evolution of the classification of neoplasms of the urinary passages.
In 1959, Friedman and Ash published the first series AFIP fascicle on the urinary bladder, which presented a classification system featuring four variants of urothelial neoplasia, adenomas, adenocarcinoma, and smooth muscle and lymphoid tumors. However, the landscape of neoplasm classification has undergone significant transformations since then, driven by advances in morphology, immunophenotype, and compelling clinical associations.
The classification of renal cell carcinomas has witnessed a profound transformation, with the emergence of numerous new entities, often characterized by distinctive genetic alterations. These breakthroughs have far-reaching implications for prognosis and treatment, underscoring the importance of staying abreast of the latest developments in this field.
This comprehensive, detailed, and highly illustrated fascicle serves as an indispensable resource for surgical pathologists and other specialists who treat patients with tumors of the urinary passages. With its wealth of insights and expertise, this publication is an essential tool for anyone seeking to stay at the forefront of this rapidly evolving field.
Product Details: Published by the American Registry of Pathology (December 30, 2021), this publication is available in English, with an ISBN-10 of 1933477172 and an ISBN-13 of 978-1933477176.
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline